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Abstract: Background: Cushing disease is uncommon challenging disease. The 
adenomas are usually small in size in most case making the disease diagnosis and 
management is sometimes difficult. In some cases, the tumor cannot be identified on 
imaging studies and in many cases the adenoma is eccentric in location adding more 
difficulties to the trans-sphenoid approach for excision of such tricky tumors. Object: to 
evaluate the challenge of diagnosis and trans-sphenoid surgery for ACTH pituitary 
microadenomas. Methods: 21 patients with ACTH secreting adenomas were involved in 
this retrospective study. All cases were operated up on via trans-sphenoid approach 
during the period from January 2009 till October 2015. All of them were microadenomas. 
All patients had obvious Cushing manifestations. In all cases magnetic resonance (MR) 
imaging and CT paranasal sinuses were performed.  In this study: cases with 
macroadenomas and recurrent cases after previous trans-sphenoid approach or gamma 
knife radiosurgery were excluded. Results: Among the 21 patients; 14 were female and 7 
weremale with age ranging from 21 to 44 years. The imaging study was positive for 
microadenoma in 18 patients while in 3 cases; no tumor was seen on the MRI imaging. 
All were operated via the trans-sphenoid approach (12 patients via the microscopic 
technique and other 9 patients via the endoscopic technique). The adenoma was 
successfully removed in 15 out of the 18 patients with evident adenoma on pre-operative 
MRI imaging while partial hypophysectomy were done in 5 cases without an evident 
adenoma on pre-operative MRI study or difficult adenoma identification. In one patient; 
the procedure was aborted because of sphenoid sinus abnormalities and the tumor was 
successfully removed via trans-cranial approach. Disease remission was achieved in 17 
patients. In 4 patients; complete remission was not achieved and gamma knife 
radiosurgery was done after surgery. Disease progression occurred in two patients with 
initial remission and was treated gamma knife radiosurgery. 13 patients had an ACTH 
deficiency after surgery while other hormonal replacement therapy is needed in only 5 
cases.  CSF rhinorrhea occurred in 2 patients and was managed with transient lumbar 
drain without any subsequent morbidities. Transient diabetes insipidus occurred in 6 
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cases and was treated conservatively. Conclusions: The transsphenoidal approach ACTH 
secreting pituitary microadenomas is considered safe and effective for achieving disease 
remission despite the challenge of diagnosis and intra-operative tumor identification. 
Key words: Adrenocorticotrophic hormone, Magnetic resonance, Computed 
tomography, Cerebrospinal fluid 
 
Introduction 
Surgery is considered the golden standard 
treatment for ACTH secreting adenomas 
causing Cushing disease. These benign 
adenomas are mostly microadenoma and 
easily achievable via the classic trans-sphenoid 
approach. However, there is still considerable 
challenges in the disease diagnosis 
management. In many cases (around 40%), the 
tumor cannot be identified on the pre-
operative imaging studies (post-contrast 
magnetic resonance imaging) and intra-
operative identification of the adenoma is 
dependent on the experience of the surgeon. 
Even if the inferior petrosal sinus sampling is 
feasible; its accuracy in identification the site 
of the adenoma is questionable.¹’²’⁹ Another 
challenge is eccentric location of many 
adenomas is eccentric and despite its small 
size; it can be very close the carotid artery 
adding more difficulties to the trans-sphenoid 
approach for excision of such tricky 
tumors.⁵’⁷’¹⁰  The goal of surgery shouldn't 
only to remove the tumor but also to preserve 
the pituitary function to prevent post-
operative hypopituitarism necessitating long 
term hormonal replacement therapy.³’⁴’⁵’⁸  
The aim of this study is to evaluate the 
challenge of diagnosis and potential 
difficulties and outcome of the trans-sphenoid 
approach for ACTH secreting pituitary 
adenomas.     
Patients and methods 
21 patients with ACTH secreting 
adenomas were involved in this retrospective 
study. All the patient had obvious clinical 
manifestations of Cushing disease. All these 
cases were operated up on in the neurosurgery 
department via the trans-sphenoidal approach 
during the period from January 2009 to 
October 2015.            
We evaluated all the medical data and 
imaging studies to assess all the potential 
difficulties in the disease diagnosis and the 
expected surgical challenge and this data was 
correlated with the operative finding and post-
operative outcome particularly the rate of 
disease remission.  Data analysis included 
patient age, gender, clinical manifestations, 
pre-operative and initial and late post-
operative hormonal levels including serum 
cortisol and ACTH levels and pre-operative 
and post-operative imaging studies.  In all 
cases, magnetic resonance (MR) imaging of 
the sellar region and CT paranasal sinuses 
were performed. In this study; cases with 
macroadenomas (greater than one CM in the 
size) and recurrent cases after previous trans-
sphenoid approach or gamma knife 
radiosurgery were excluded. Outcome 
assessment was evaluated by improvement of 
the Cushing manifestation, hormonal 
assessment to ensure biochemical remission 
and post-operative contrast enhancing 
magnetic resonance imaging. Post-operative 
cortisol level evaluation was routinely done on 
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the first day after the surgery and then after 
one, three and six months thereafter. Then 
hormonal evaluation was done annually for 
assessment of any relapse. Remission was 
defined by either normalization of the serum 
cortisol level or those with low serum cortisol 
level (≤3 mg/dl) necessitating hormonal 
replacement therapy. Those patients with 
remaining elevated serum cortisol level were 
considered treatment failure.  Post-operative 
imaging (MRI) was done initially after three 
months to ensure any residual tumor and then 
annually for five years to detect any 
recurrence. Post-operative morbidities 
(transient or permanent) were also analyzed.  
Results 
Among the 21 patients; 14 were females 
and 7 were males with age ranging from 21 to 
44 years (mean 33.6). All patients had the 
clinical manifestation of Cushing disease 
(Table 1). Headache was manifest in eleven 
patients, 2 patients had ocular palsy 
concomitant with his Cushing manifestation 
(Figure 1), and in one patient; impotence was 
his early presentation for Cushing disease. In 
three patients; uncontrolled diabetes was the 
triggering for the diagnosis of the disease and 
in one patient refractory hypertension was the 
initial presentation. Depending on the pre-
operative post-contrast magnetic resonance 
study; we have 2 categories of patients; those 
with positive microadenoma (18 patients) and 
those with negative finding (3 patients).  All 
patients were operated up on via the trans-
sphenoid approach (12 patients via the 
microscopic endonasal technique and other 9 
patients via the endoscopic endonasal 
technique) (Table 2). The technique was 
exactly like what was widely described in the 
literature but we have faced with difficulties 
from mucosal changes rendering it more 
friable and bloody and difficulties from 
difficult control of the blood pressure.  In one 
patient with conical shaped sinus; drilling of 
the bony sinus was performed under image 
guidance but bleeding was evident and the 
approach was aborted and the adenoma was 
removed three weeks later via the trans-cranial 
approach.
TABLE I 
Patients characteristics 
Male 7 
Female 14 
Male-female ratio: 1:2 
Patient sex 
21 to 44 years (mean 33.6) Age 
Headache: 11 patients 
Diabetes: 12 patients 
(Three of them was the initial presentation) 
Hypertension:13 patients 
(One of them was the initial presentation) 
Skin changes: 19 patients 
Abnormal fat distribution: 18 patients 
Impotence: 1 patients  
Clinical presentation 
(Cushing manifestation) 
9 months - 78 months Follow up period 
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TABLE II 
Imaging characteristic, Treatment plan and outcome of surgery 
Positive for adenoma: 18 patients 
Negative for adenoma: 3 patients 
Pre-operative MRI of the sella 
Microscopic trans-sphenoidal approach: 12 patients 
Endoscopic trans-sphenoidal approach: 9 patients   
Technique of surgery 
Adenoma removal:  
15 via the trans-sphenoidal approach 
One via additional trans-cranial approach after aborted Tans-sphenoid 
approach 
 
Partial hypophysectomy: 5 patients 
Intra-operative finding 
Positive:18 patients  
Negative: 3patients 
Pathological confirmation of 
adenoma 
Gamma knife radiosurgery: 6 patients 
4 patients: treatment failure 
2 patients: disease progression after initial remission 
Medical treatment: 
Cortisol replacement therapy:13 patients 
Other hormonal replacement therapy: 5 patients 
Post-operative treatment 
CSF rhinorrhea: 3 patients (Transient) 
Transient diabetes insipidus: 6 patients 
Surgery related morbidities 
 
TABLE III 
Disease remission (Biochemical markers) 
Disease remission: 17 patients (80.9%) 
              Immediate after surgery: 8 patients 
              Within 6 months from surgery: 7 patients 
              Up to one year from surgery: 2 patients 
Failure to achieve remission: 4 patients (19.1%) 
Disease progression after initial remission: 2 patients (9.5%) 
Remission in relation to pathological confirmation: 
             Positive adenoma (15 patients): 14 patients achieved remission 
             Mixed adenoma and hyperplasia (3 patients): two achieved remission 
             Negative specimen (3 patients): one achieved remission 
Post-operative cortisol level: 
Hypocortisolemia: 13 patients 
Eucortisolemia: 4 patients  
Persistent hypercortisolemia: 4 patients 
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The adenoma was successfully removed in 
15 out of the 18 patients with evident adenoma 
on pre-operative post-contrast magnetic 
resonance study (Figure 2) while partial 
hypophysectomy were done in 5 cases without 
an evident adenoma on pre-operative MRI 
study or difficult adenoma identification. 
Pathological confirmation for the adenoma 
was achieved in 15 patients, mixed adenoma 
and hyperplasia in 3 patients while specimen 
was negative in three cases. Follow up period 
ranged from 9 months up to 78 months. 
Disease remission (Table 3) was achieved in 17 
patients (80.9%). In 4 patients (19.1%); 
complete remission was not achieved and 
gamma knife radiosurgery was done after 
surgery. Disease progression occurred in two 
patients (9.5%) after initial remission and was 
treated with gamma knife radiosurgery.  
No approach related mortalities occurred. 
13 patients had post-operative cortisol 
deficiency and was maintained on 
replacement therapy.  Other hormonal 
replacement therapy was needed in only 5 
cases.  CSF rhinorrhea occurred in 2 patients 
and was managed with transient lumbar drain 
without any subsequent morbidities. Also, the 
case that was operated via the trans-cranial 
approach after failed trans-sphenoid surgery 
developed CSF rhinorrhea after 2nd surgery 
and was managed with transient lumbar drain. 
Transient diabetes insipidus occurred in 6 
cases and was treated conservatively.   
Discussion 
Cushing disease is uncommon challenging 
disease. It occurs due to ACTH secreting 
adenomas which in majority of cases are 
microadenomas but many reports showed that 
macroadenomas can cause up to 13% of 
Cushing disease patients.⁶’⁸’⁹’¹¹’¹³’¹⁴ However, 
we decided to concentrate in this reports on 
challenge and outcome of surgery for de novo 
cases of ACTH secreting adenomas rather 
than macroadenomas or previously treated 
cases to stress on the challenge of treatment 
and outcome of such small lesion not to 
involve other potential challenge rather than 
the adenoma itself.¹’³’⁶’¹¹’¹²           
The female predominance and age 
distribution in our study matches with the 
finding of other reports.¹’²’⁵’⁷’⁹ The challenge 
of this disease starts with disease diagnosis. 
Several factors are important in the endeavor 
to obtain satisfactory results. Preoperative 
detection of the ACTH secreting adenoma is 
crucial for the surgical outcome, achievement 
of cure and prevention of surgically induced 
hypopituitarism.⁸’¹⁰’¹⁵’¹⁶’¹⁷ Our 1st problem 
was with three cases (14.3%) with all 
manifestation of Cushing disease with 
exclusion with all potential differential 
diagnosis with negative finding of the post-
contrast magnetic resonance of the sella. Our 
incidence of negative imaging is lower than 
what reported in other studies which may 
reach up to 40% of Cushing microadenomas 
which mostly due to lack of referral of MRI 
negative patients to our neurosurgical 
service.⁶’⁷’¹¹’¹²’¹³’¹⁷Although inferior petrosal 
sampling played a role in identification the site 
of adenoma however we don't have such 
facility and in many reports, its accuracy is up 
to 60% in identification the site of 
adenoma.³’⁴’⁹’¹⁰’¹¹ In such cases our decision 
was to explore the pituitary gland for the 
adenoma or do partial hypophysectomy.  
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The trans-sphenoid technique is exactly 
like what have been reported in different series 
and there was no difference between the 
microscopic versus the endoscopic approach 
for addressing such tiny adenomas.¹’²’⁵’⁸’¹⁶’¹⁷ 
However, in our cases there was a potential 
challenge in the approach specific to this 
problem in the form of friable bloody nasal 
mucosa adding some difficulties to the nasal 
step of the approach. Another problem was the 
difficult control of the blood pressure during 
the procedure that increased the bleeding 
during the nasal phase of the approach. In one 
case; the sphenoid sinus was conical shaped 
type and under C arm guidance we tried to 
drill the bony sinus to reach the sellar floor but 
due to excessive bleeding and lack of 
navigation system under our facilities; we 
decided to abort the procedure and to come 
back from above via trans-cranial approach 
and the adenoma was removed. In five 
patients, no adenoma could be identified 
during pituitary gland exploration and partial 
hypophysectomy was performed.  Many 
reports addressed the issue of negative 
exploration of pituitary gland for adenoma 
and advocated hemi-hypophysectomy of 
pituitary gland particularly on the side of 
positive inferior petrosal sampling with 
reported cases of disease remission even with 
absence of any pathological 
confirmation.⁶’⁹’¹⁰’¹¹’¹⁴’¹⁷  
The issue of Cushing disease remission both 
clinically and by biological confirmation has 
been addressed in many reports with overall 
remission ranging from 59 to 98% in different 
clinical series.²’⁴’⁵’⁸’⁹ Variable factors predict the 
potential remission rate; the size of adenoma, 
whether its de novo or recurrent, presence of 
cavernous sinus invasion and presence or 
absence of pathological confirmation. Remission 
rate is higher in newly diagnosed 
microadenomas without cavernous sinus 
invasion and slightly higher in pathologically 
proven adenoma rather than those with 
inconclusive pathological smear.¹’²’⁷’¹²’¹³’¹⁴ We 
have achieved remission in 80.9% of cases but all 
of them is microadenomas. In one case; the 
adenoma was located laterally in close contact 
with internal carotid artery and despite 
pathological confirmation of being adenoma; 
remission wasn't achieved and was sent for 
gamma knife (Figure 1). Among our three cases 
with negative pathological confirmation; only 
one case (33.3%) showed disease remission and 
other two cases were sent for gamma knife. 
 
 
Figure 1 - MRI images of case with Cushing disease with uncontrolled diabetes presented with ptosis due to 3rd 
nerve palsy 
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Figure 2 - A case of Cushing disease removed via microscopic trans-sphenoid approach. The above image showed 
her pre-operative picture and that one and three years after surgery with regression of all Cushing manifestations 
and the below image showed her pre-operative and post-operative MRI with total removal of her adenoma 
 
In another case that post-operative remission 
wasn't achieved; the pathological smear revealed 
mixed adenoma and hyperplasia and the patient 
was also referred for gamma knife treatment.   
Recurrence of disease is not uncommon 
and it can happen over many years after initial 
remission hence long term follow up is 
necessary for those patients. Overall 
recurrence rate ranged from 5 % to 60 % in 
many case series and it can occur up to 10 years 
from remission.⁹’¹⁰’¹¹’¹³’¹⁴ Recurrence is more 
expected in cases of macroadenomas, 
cavernous sinus invasion and with negative 
pathological confirmations or when the 
hyperplasia rather than adenoma is the cause 
of the disease.²’³’⁴’⁸’¹⁷ In our cases; we have two 
cases (9.5%) of disease progression after initial 
remission. The pathology in one of them was 
mixed adenoma and hyperplasia and was 
advised to have gamma knife treatment. The 
2nd case showed recurrent adenoma on post-
operative magnetic resonance study but the 
patient preferred to do gamma knife 
radiosurgery rather than the advised repeated 
trans-sphenoid approach. Complication after 
trans-sphenoid surgery for Cushing disease is 
relatively high compared to other pituitary 
adenomas and it may reach up to 53% in some 
reports.⁴’⁹’¹¹’¹⁵ Also, mortality rate has been 
reported up to 8.4%. Complications could be 
minor and transient or it may be permeant or 
even life threatening. Reported morbidities 
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included Epistaxis, pituitary hypofunction, 
CSF leakage, pneuomocephalus, meningitis, 
visual impairment, ocular motility 
dysfunction, and occasional deep venous 
thrombosis and pulmonary 
embolism.⁵’⁶’⁷’⁸’¹⁴’¹⁶’¹⁷ Some reports⁹’¹⁰’¹¹’¹²’¹³ 
claimed that morbidity was less with 
endoscopic procedures rather than with 
microscopic technique but in our study; there 
was no much difference. Our reported 
morbidities included transient CSF rhinorrhea 
(2 patients), transient diabetes insipidus (6 
cases) and hypopituitarism (5 patients). 
Another case that was operated via the trans-
cranial approach after failed trans-sphenoid 
surgery developed CSF rhinorrhea after 2nd 
surgery and was managed with transient 
lumbar drain.  13 patients had post-operative 
cortisol deficiency and was maintained on 
replacement therapy.   
Conclusions 
The transsphenoidal approach for ACTH 
secreting pituitary microadenomas is 
considered safe and effective for achieving 
disease remission despite the challenge of 
diagnosis and intra-operative tumor 
identification. Both microscopic and 
endoscopic techniques are of equal safety and 
efficacy. Both pre-operative tumor 
identification on magnetic resonance imaging 
of the sella and positive pathological 
confirmation of removed tissue play a role in 
achievement of remission. Disease progression 
may occur after initial remission hence long 
term follow up of those patients is necessary.  
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